Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
Medicine and Science in Sports and Exercise|February 1, 1993
Visual loss and performance in blind athletesV I Makris, R D Yee, C D Langefeld, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1987
Problems and pitfalls in the isolation of an endogenous Na+, K+-ATPase inhibitorM A Mir, K Morgan, M Lewis, et al.
The International Journal of Biochemistry & Cell Biology|March 29, 2000
Karyotypic abnormalities associated with haemopoietic lineage switching are not linked with mutations to p53S M Colley, D S Chappell, S J Busfield, et al.
Neurology|March 29, 2007
AMPA potentiator treatment of cognitive deficits in Alzheimer diseaseA S Chappell, C Gonzales, J Williams, et al.
The Clinical Journal of Pain|May 21, 2009
A 1-year safety and efficacy study of duloxetine in patients with fibromyalgiaAmy S Chappell, Geoffrey Littlejohn, Daniel K Kajdasz, et al.
International Journal of General Medicine|April 30, 2010
A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgiaAmy S Chappell, Laurence A Bradley, Curtis Wiltse, et al.
Diabetes/Metabolism Research and Reviews|July 29, 2009
Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic painVladimir Skljarevski, Durisala Desaiah, Qi Zhang, et al.
Journal of Neurotrauma|November 1, 2001
Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in ratsL Belayev, O F Alonso, Y Liu, et al.
Pain Practice : the Official Journal of World Institute of Pain|July 7, 2010
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the kneeAmy S Chappell, Durisala Desaiah, Hong Liu-Seifert, et al.
Pageof 19